Patents by Inventor Gregor Sedmak

Gregor Sedmak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND USES THEREOF
    Publication number: 20230092490
    Abstract: Pharmaceutical compositions comprising dasatinib anhydrous provide an improved, pH-independent dissolution profile compared with pharmaceutical compositions comprising dasatinib monohydrate. Thus, pharmaceutical compositions comprising dasatinib anhydrous can be used in the treatment of chronic myelogenous leukaemia (CML) and/or Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL), especially in subjects having an increased gastric pH and/or in subjects being co-administered with a gastric acid reducing agent.
    Type: Application
    Filed: March 5, 2021
    Publication date: March 23, 2023
    Applicant: ZENTIVA K.S.
    Inventors: Gregor SEDMAK, Martin NOVAK, Ales BARTUNEK, Jiri HOFMANN
  • PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF
    Publication number: 20130190487
    Abstract: The present invention relates to the method of preparing of ezetimibe and in particular to novel intermediates for its synthesis and an improved process for preparing such intermediates. Said intermediates may be obtained in high yields and purity in a fast and cost efficient manner. The present invention relates to a novel crystalline form of ezetimibe as well.
    Type: Application
    Filed: January 24, 2008
    Publication date: July 25, 2013
    Applicant: KRKA
    Inventors: Anton Stimac, Barbara Mohar, Michel Stephan, Mojca Bevc, Rok Zupet, Andrej Gartner, Vesna Kroselj, Matej Smrkolj, Davor Kidemet, Gregor Sedmak, PRIMOZ BENKIC, ALEN KLJAJIC, MIHA PLEVNIK